1. Home
  2. ABLV vs CCEL Comparison

ABLV vs CCEL Comparison

Compare ABLV & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ABLV

Able View Global Inc.

HOLD

Current Price

$0.74

Market Cap

39.5M

Sector

N/A

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.41

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABLV
CCEL
Founded
2015
1989
Country
China
United States
Employees
N/A
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.5M
32.7M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
ABLV
CCEL
Price
$0.74
$3.41
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
19.6K
16.4K
Earning Date
09-30-2025
02-27-2026
Dividend Yield
N/A
11.70%
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$114,319,869.00
$31,747,500.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
$15.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$3.10
52 Week High
$1.77
$8.79

Technical Indicators

Market Signals
Indicator
ABLV
CCEL
Relative Strength Index (RSI) 56.53 42.46
Support Level $0.65 $3.37
Resistance Level $0.77 $3.53
Average True Range (ATR) 0.07 0.21
MACD 0.01 0.02
Stochastic Oscillator 64.29 32.21

Price Performance

Historical Comparison
ABLV
CCEL

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: